Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice
Authors
Keywords
-
Journal
Mucosal Immunology
Volume 6, Issue 2, Pages 393-404
Publisher
Springer Nature
Online
2012-09-12
DOI
10.1038/mi.2012.83
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cutting Edge: Cooperation of IPS-1- and TRIF-Dependent Pathways in Poly IC-Enhanced Antibody Production and Cytotoxic T Cell Responses
- (2014) H. Kumar et al. JOURNAL OF IMMUNOLOGY
- Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow
- (2011) A. Zarbock et al. BLOOD
- Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN
- (2011) S. M. Geary et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors
- (2011) Loane Decrausaz et al. INTERNATIONAL JOURNAL OF CANCER
- Unraveling Molecular Signatures of Immunostimulatory Adjuvants in the Female Genital Tract through Systems Biology
- (2011) Madelene Lindqvist et al. PLoS One
- Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
- (2010) S Daayana et al. BRITISH JOURNAL OF CANCER
- A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers
- (2010) Loane Decrausaz et al. INTERNATIONAL JOURNAL OF CANCER
- Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population
- (2010) Lis R.V. Antonelli et al. JOURNAL OF CLINICAL INVESTIGATION
- Pattern Recognition via the Toll-Like Receptor System in the Human Female Genital Tract
- (2010) Kaei Nasu et al. MEDIATORS OF INFLAMMATION
- CXCR3 and CCR5 are both required for T cell-mediated protection against C. trachomatis infection in the murine genital mucosa
- (2010) A J Olive et al. Mucosal Immunology
- Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG
- (2010) Jasper G. van den Boorn et al. PLoS One
- ORIGINAL ARTICLE: Two Different Homing Pathways Involving Integrin β7 and E-selectin Significantly Influence Trafficking of CD4 Cells to the Genital Tract Following Chlamydia muridarum Infection
- (2009) Kathleen A. Kelly et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- The Therapeutic Vaccine: Is it Feasible?
- (2009) Lutz Gissmann et al. ARCHIVES OF MEDICAL RESEARCH
- Class C CpG oligodeoxynucleotides as a single agent and in combination with radiotherapy efficiently delayed growth of subcutaneous B16F1 tumors
- (2009) Petra Cerkovnik et al. Innate Immunity
- Bacterial DNA Activates Endothelial Cells and Promotes Neutrophil Adherence through TLR9 Signaling
- (2009) D. El Kebir et al. JOURNAL OF IMMUNOLOGY
- Intranasal Administration of CpG Induces a Rapid and Transient Cytokine Response Followed by Dendritic and Natural Killer Cell Activation and Recruitment in the Mouse Lung
- (2009) Isabella Pesce et al. Journal of Innate Immunity
- Route of Administration of the TLR9 Agonist CpG Critically Determines the Efficacy of Cancer Immunotherapy in Mice
- (2009) Stefan Nierkens et al. PLoS One
- Monitoring of Vaccine-Specific Gamma Interferon Induction in Genital Mucosa of Mice by Real-Time Reverse Transcription-PCR
- (2008) V. Revaz et al. Clinical and Vaccine Immunology
- CpG Oligodeoxynucleotides Alter Lymphocyte and Dendritic Cell Trafficking in Humans
- (2008) W. N. Haining et al. CLINICAL CANCER RESEARCH
- Topical CpG Enhances the Response of Murine Malignant Melanoma to Dacarbazine
- (2008) Hossain M. Najar et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
- (2008) John T. Schiller et al. VACCINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started